Rituximab in B-cell disorders other than non-Hodgkin's lymphoma.
Bosly, Andre
Rituximab in B-cell disorders other than non-Hodgkin's lymphoma. [electronic resource] - Anti-cancer drugs Nov 2002 - S25-33 p. digital
Publication Type: Journal Article; Review
0959-4973
Anemia, Hemolytic, Autoimmune--drug therapy
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents--therapeutic use
B-Lymphocytes--pathology
Clinical Trials as Topic
Hematologic Diseases--drug therapy
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Lymphoproliferative Disorders--drug therapy
Organ Transplantation--adverse effects
Paraproteinemias--drug therapy
Purpura, Thrombocytopenic, Idiopathic--drug therapy
Rituximab
Rituximab in B-cell disorders other than non-Hodgkin's lymphoma. [electronic resource] - Anti-cancer drugs Nov 2002 - S25-33 p. digital
Publication Type: Journal Article; Review
0959-4973
Anemia, Hemolytic, Autoimmune--drug therapy
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents--therapeutic use
B-Lymphocytes--pathology
Clinical Trials as Topic
Hematologic Diseases--drug therapy
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Lymphoproliferative Disorders--drug therapy
Organ Transplantation--adverse effects
Paraproteinemias--drug therapy
Purpura, Thrombocytopenic, Idiopathic--drug therapy
Rituximab